Reports FY23 revenue $570,000 vs $275,000 last year.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VCNX:
- Vaccinex Reports 2023 Financial Results and Provides Corporate Update
- Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
- Vaccinex prices 193,000 shares at $7.77 in registered direct offering
- Biotech Alert: Searches spiking for these stocks today
- Vaccinex Inc Broadens Reach with ActivMab® Technology Deals